Promising Results from Small Preliminary Trial of mRNA Vaccine Used to Treat Pancreatic Cancer


A clinical trial tested the use of an mRNA vaccine against patients who had received surgery for pancreatic cancer. The small trial showed that half of the patients who received the vaccine after surgery did not have recurrence of the tumor a year and a half later. 

To read the full article from Scientific American by Tanya Lewis, click here

Comments are closed.

Skip to toolbar